QP4-18085-56382
3 vaccinations
1 coded response
3 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 16-20
- ZIP prefix
- 951 / CA
- Registered
- 2022-04-23
- Relationship
- Child or adolescent in my care
- Guardian
- 3ME-24552-71030
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2021-03-25
Dose 1 — Pfizer-BioNTech
-
2021-04-16
Dose 2 — Pfizer-BioNTech
-
2022-04-23
Registered in v-safe
-
2022-05-31
Dose 3 — Pfizer-BioNTech
-
2022-06-02
Survey response — days 1–6 daily, dose 3, dependentMedDRA: Chills, Nausea — Feeling: Fair · Site: Pain, Swelling · Headache, Joint pains, Muscle or body aches, Fatigue or tirednessFree text: Had chills yesterday and nauseaMedDRA releases: 2024-11 · check-in free text available
-
2022-06-06
Health check-in — days 1–6 daily, dose 3, dependentFeeling: Poor · Fever · Fatigue or tiredness, Nausea, Diarrhea, Abdominal pain · Be unable to do your normal daily activitiesAdult check-in
- 2022-09-01
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-25 | Pfizer-BioNTech | No |
| 2 | 2021-04-16 | Pfizer-BioNTech | No |
| 3 | 2022-05-31 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 3, dependent
Systemic reaction (other): Had chills yesterday and nausea
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Chills | · | · | ✓ |
| SRO | Nausea | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release